Home › Funds › Rubric Capital Management LP › ARQT

Rubric Capital Management LP position in ARQT

ARCUTIS BIOTHERAPEUTICS INC · Health Care

Rubric Capital Management LP reported holding 8,271,577 shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$216.9M, representing 2.00% of its reported portfolio and ranking #13 among its reported holdings. Rubric Capital Management LP has disclosed ARQT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)8.27M sh
Reported value held$216.88M
Portfolio Weight2.00%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rubric Capital Management LP's ARQT position evolved

Rubric Capital Management LP first disclosed a stake in ARQT in Q3 2023 at 5,034,530 shares (US$26.7M). The position peaked in Q4 2025 at 8,271,577 shares, worth US$240.2M. Across 12 filings, Rubric Capital Management LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 8,271,577 shares valued at US$216.9M. Notable position changes include a 32% increase in Q4 2023 (shares rose 207% over the following quarter), a 31% increase in Q2 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.03M $26.73M New
Q4 2023 6.64M $21.46M Add
Q1 2024 7.51M $74.42M Add
Q2 2024 9.82M $91.30M Add
Q3 2024 10.97M $101.99M Add
Q4 2024 10.97M $152.77M Hold
Q1 2025 10.97M $171.52M Hold
Q2 2025 10.75M $150.71M Reduce
Q3 2025 10.75M $202.63M Hold
Q4 2025 8.27M $240.21M Reduce
Q1 2026 8.27M $194.88M Hold
Q2 2026 8.27M $216.88M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARQT and 13F data

ARQT (ARCUTIS BIOTHERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ARQT — the largest reported positions include MONTANOVA CAPITAL, LLC (US$326.1M), Frazier Life Sciences Management, L.P. (US$258.9M), ORBIMED ADVISORS LLC (US$53.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARQT

All ARQT fund holders →

FAQ

How long has Rubric Capital Management LP held ARQT?

Rubric Capital Management LP has disclosed ARQT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Rubric Capital Management LP's current position in ARQT?

As of Q2 2026, Rubric Capital Management LP holds 8.27M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), valued at $216.88M, representing 2.00% of its reported portfolio and ranking #13.

Has Rubric Capital Management LP been buying or selling ARQT?

In the latest 13F filing (Q2 2026), Rubric Capital Management LP held unchanged its position in ARQT. The position peaked in Q4 2025 at 8.27M shares.

Which other funds hold ARQT?

Other major institutional holders of ARQT include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., ORBIMED ADVISORS LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.